Pharma Industry
Latest News
Advertisement
Latest Videos
Shorts
1:00
Is tech worth the investment for small clinics?
2 days ago
by
Dean Erhardt
0:52
Can tech solve the health care worker shortage?
5 days ago
by
Dean Erhardt
3:00
CMS finalizes Medicaid work requirements; Trump's AI order and what it signals; how Americans really read drug labels — Morning Medical Update Weekly Recap
8 days ago
by
Austin Littrell
1:14
The future of health care — adapting to AI scribes and robot doctors
8 days ago
by
Dean Erhardt
0:57
Adapt to AI or get left behind — the horse and buggy analogy
11 days ago
by
Dean Erhardt
2:55
Utah's AI prescription pilot survives pushback; surprise-billing dispute overhaul; uninsured rate steady at 8% — Morning Medical Update Weekly Recap
15 days ago
by
Austin Littrell
3:06
TrumpRx expands, partners with Mark Cuban; Senate Democrats target WISeR; pediatric anxiety up 300% — Morning Medical Update Weekly Recap
22 days ago
by
Austin Littrell
1:08
Medical research and need: A good match or mismatch?
7 months ago
by
Donald Berwick, MD, MPP, FRCP, KBE
Advertisement
More News
But some of the state’s top physicians and clinicians say they were blindsided by the pilot program.
The top news stories in medicine this week.
When it comes to filling prescriptions, having a nearby pharmacy isn't always enough.
Everyday prescriptions such as atorvastatin, lisinopril and metformin are now on the federal price comparison site, though experts say insured patients still may pay less through their plans.
Here’s how three states used Medicaid policies to cut costs and improve accountability by reining in pharmacy benefit managers
No physician wants to write a prescription that their patient can’t afford. But having affordability information, such as co-pays and vouchers or discounts, embedded into the EHR encourages better conversations between patients and providers about medication costs and support options.
The sad reality is that too many Americans are ingesting a daily cocktail of Big Pharma prescribed by multiple doctors who typically don’t talk to each other or know each other.
What physicians need to know about a massive program that affects prices of medicines.
Medicare has a laudable goal to bargain for lower prices, but there’s a chance patients could lose out on billions in savings.
Vaccines, autism are part of Senate questioning as Casey Means, M.D., says she supports physicians and patients making decisions rather than depending on surgeon general pronouncements.
Trump spotlights drug-price transparency and Most Favored Nation pricing —signaling changes to Obamacare subsidies and hospital insurer rules.
Express Scripts says it has the same goal as the Federal Trade Commission: ‘Lowering drug costs for Americans.’
President Trump signed federal spending plan with new rules for PBMs; a leading PBM trade group says Big Pharma is to blame for high drug prices.
Pharma, MedTech and diagnostics still operate in separate lanes even as precision medicine, value-based care and outcome-focused models demand integrated systems of care.
New white paper argues pharmacy benefit managers’ slim margins reflect bookkeeping and consolidation, not necessarily low profits, as oversight push intensifies.
An explainer of the new initiative to lower costs for patients while reining in pharmaceutical makers, PBMs and insurance companies.
What clinicians should keep in mind when recommending LAI medications and helping patients receive consistent treatment
Advertisement
Advertisement
Trending on Medical Economics
1
Why physicians make so much and still feel broke
2
The $100,000 H-1B fee: Impact on the health care sector, legal challenge and current status
3
Hear better, sleep better, think better: What physicians should know about dementia risk
4
Empowerment over uncertainty: 5 keys to strengthen physician leadership in turbulent times
5